查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1573158

心臟復健市场：按患者类型、復健类型、计划类型、最终用户、阶段类型、组成部分、年龄组划分 - 2025-2030 年全球预测

Cardiac Rehabilitation Market by Patient Types (Acute Patients, Chronic Patients), Rehabilitation Types (Inpatient Rehabilitation, Outpatient Rehabilitation), Program Types, End Users, Phase Types, Components, Age Groups - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年心臟復健市场价值为20.3亿美元，预计到2024年将达到21.2亿美元，复合年增长率为5.57%，预计到2030年将达到29.7亿美元。

心臟復健（CR）包括综合调理介入措施，旨在优化心血管疾病患者的身体、心理和社会功能。该计划整合了运动训练、生活方式改变和药物治疗，以预防随后的心臟事件。该计划的需求源于与心臟病相关的高发病率和死亡率，强调其在医院、诊所和家庭环境中的应用。最终用途包括心肌梗塞、冠状动脉绕道手术手术、经皮冠状动脉介入治疗和心臟衰竭患者。市场洞察表明，人们对 CR 益处的认识不断增强、易患冠状动脉疾病的老年人口不断增加，以及远距復健计画等技术进步是关键的成长要素。将 CR 计划扩展到卫生基础设施正在改善的发展中地区，并强调行动医疗(行动医疗 ) 解决方案以扩大可及性，大流行后存在潜在机会转向远端医疗服务，这加剧了这种情况。然而，该计划的局限性包括成本高、保险范围有限、提供者转诊率低以及患者依从性挑战。此外，低收入地区还存在基础设施和熟练人力资源不足等其他障碍。为了实现业务成长，应专注于开发负担得起且可扩展的远距心臟復健平台和个人化復健方案，利用人工智慧和机器学习根据个别患者情况客製化方案创新。透过鼓励政策调整以支持更好的保险覆盖范围和宣传宣传活动以提高提供者转介率，可以进一步扩大市场。该行业似乎充满活力，持续创新和政策合作对于持续成长至关重要，并为灵活、技术主导的康復解决方案的早期采用者提供了有利的竞争环境。

主要市场统计
基准年[2023] 20.3亿美元
预测年份 [2024] 21.2亿美元
预测年份 [2030] 29.7亿美元
复合年增长率（%） 5.57%

市场动态：揭示快速发展的心臟復健市场的关键市场洞察

供需的动态交互作用正在改变心臟復健市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 增加医疗保健支出，重点关注慢性病管理和预防性健康服务
    • 扩大综合心臟復健治疗的保险范围和报销政策
    • 开发穿戴式科技和远端监控工具以促进患者持续参与
  • 市场限制因素
    • 心臟復健计划的高成本阻碍了患者的註册和参与
  • 市场机会
    • 开发人工智慧驱动的工具来早期检测和管理心臟疾病
    • 医疗保健提供者和健身中心之间的合作，提供全面的心臟復健解决方案
  • 市场挑战
    • 不一致的保险范围和报销政策影响患者获得心臟復健服务

波特五力：驾驭心臟復健市场的策略工具

波特的五力框架是了解心臟復健市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解心臟復健市场的外部影响

外部宏观环境因素在塑造心臟復健市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解心臟復健市场的竞争状况

对心臟復健市场的详细市场占有率分析可以对供应商的表现进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵心臟復健市场供应商绩效评估

FPNV定位矩阵是评估心臟復健市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了心臟復健市场的成功之路

心臟復健市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 增加医疗支出，重点关注慢性病管理和预防性医疗服务
      • 扩大综合护理的保险覆盖范围和报销政策
      • 开发穿戴式科技和远端监控工具以促进病人参与
    • 抑制因素
      • 心臟復健计划的高成本阻碍了患者的註册和参与
    • 机会
      • 开发人工智慧驱动的工具来早期检测和管理心臟病
      • 透过医疗保健提供者和健身中心之间的合作提供全面的心臟復健解决方案
    • 任务
      • 不一致的保险范围和报销政策影响患者获得心臟復健服务
  • 市场区隔分析
  • 波特五力分析
  • PESTLE分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章依病患类型分類的心臟復健市场

  • 急性病人
    • 术后
    • 刚出院
  • 慢性病人
    • 心臟衰竭管理
    • 长期追踪

第七章依復健类型分類的心臟復健市场

  • 住院復健
    • 急性护理
    • 监控服务
  • 门诊復健
    • 运动疗法
      • 有氧运动
      • 阻力训练
    • 营养咨询
    • 心理支持

第八章按项目类型分類的心臟復健市场

  • 以社区为基础的计划
  • 家庭计划
  • 传统节目

第九章心臟復健市场：依最终用户分类

  • 家庭护理设置
  • 医院
  • 专科诊所

第10章依阶段类型分類的心臟復健市场

  • 第一阶段
  • 第二阶段
  • 第三阶段

第十一章心臟復健市场：依组成部分

  • 行为成分
  • 教育成分
  • 运动组件

第十二章依年龄分類的心臟復健市场

  • 成人用
  • 老年病
  • 小儿科

第十三章美洲心臟復健市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第14章亚太地区心臟復健市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十五章欧洲、中东和非洲心臟復健市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十六章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议
Product Code: MRR-2B5802CFEB48

The Cardiac Rehabilitation Market was valued at USD 2.03 billion in 2023, expected to reach USD 2.12 billion in 2024, and is projected to grow at a CAGR of 5.57%, to USD 2.97 billion by 2030.

Cardiac rehabilitation (CR) encompasses a comprehensive range of coordinated interventions designed to optimize the physical, psychological, and social functionality of individuals with cardiovascular diseases. The program integrates exercise training, lifestyle modification, and pharmacotherapy to prevent subsequent cardiac events. Its necessity arises from the high prevalence and mortality rate associated with heart diseases, underlining its application in hospitals, clinics, and home-based settings. The end-use scope covers patients post myocardial infarction, coronary artery bypass grafting, percutaneous coronary intervention, or heart failure. Market insights reveal that the growing awareness of the benefits of CR, an increasing geriatric population prone to coronary diseases, and technological advancements such as tele-rehabilitation programs are key growth factors. Potential opportunities exist in expanding CR programs to developing regions where healthcare infrastructure is improving, as well as emphasizing mobile health (mHealth) solutions to broaden accessibility, which is exacerbated by post-pandemic shifts towards remote healthcare delivery. However, limitations involve the high costs of programs, limited insurance coverage, and low referral rates by healthcare providers, as well as patient adherence challenges. Moreover, the market faces barriers such as inadequate infrastructure and skilled personnel in low-income areas. To unlock business growth, innovation should focus on developing affordable, scalable tele-cardiac rehabilitation platforms and personalized rehabilitation regimens utilizing AI and machine learning to tailor programs to individual patient profiles. Encouraging policy adjustments to support better insurance coverage and awareness campaigns to improve healthcare provider referral rates could further expand market reach. The industry appears dynamic with continued innovation and policy cooperation being essential for sustained growth, presenting a competitive environment beneficial for early-adopters of tech-driven and flexible rehabilitation solutions.

KEY MARKET STATISTICS
Base Year [2023] USD 2.03 billion
Estimated Year [2024] USD 2.12 billion
Forecast Year [2030] USD 2.97 billion
CAGR (%) 5.57%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cardiac Rehabilitation Market

The Cardiac Rehabilitation Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising healthcare expenditures focused on chronic disease management and preventive healthcare services
    • Expansion of insurance coverage and reimbursement policies for comprehensive cardiac rehabilitation therapies
    • Developments in wearable technology and remote monitoring tools facilitating continuous patient engagement
  • Market Restraints
    • High cost of cardiac rehabilitation programs deterring patient enrollment and participation
  • Market Opportunities
    • Development of AI-powered tools for early detection and management of cardiac conditions
    • Collaborations between healthcare providers and fitness centers for comprehensive cardiac rehabilitation solutions
  • Market Challenges
    • Inconsistent insurance coverage and reimbursement policies affecting patients' access to cardiac rehabilitation services

Porter's Five Forces: A Strategic Tool for Navigating the Cardiac Rehabilitation Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cardiac Rehabilitation Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cardiac Rehabilitation Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cardiac Rehabilitation Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cardiac Rehabilitation Market

A detailed market share analysis in the Cardiac Rehabilitation Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cardiac Rehabilitation Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cardiac Rehabilitation Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cardiac Rehabilitation Market

A strategic analysis of the Cardiac Rehabilitation Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cardiac Rehabilitation Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Allscripts Healthcare Solutions, AstraZeneca, Boston Scientific, Cleveland Clinic, Core Health & Fitness, Edward Lifesciences Corporation, GE Healthcare, Johns Hopkins Medicine, LifeWatch, Mayo Clinic, Medtronic, Mortara Instrument, Novartis, Omron Healthcare, Pfizer, Philips Healthcare, Resideo Technologies, Siemens Healthineers, and Smiths Medical.

Market Segmentation & Coverage

This research report categorizes the Cardiac Rehabilitation Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Patient Types, market is studied across Acute Patients and Chronic Patients. The Acute Patients is further studied across Post-Surgical and Recently Discharged. The Chronic Patients is further studied across Heart Failure Management and Long-Term Follow-Up.
  • Based on Rehabilitation Types, market is studied across Inpatient Rehabilitation and Outpatient Rehabilitation. The Inpatient Rehabilitation is further studied across Acute Care and Monitoring Services. The Outpatient Rehabilitation is further studied across Exercise Therapy, Nutrition Counseling, and Psychological Support. The Exercise Therapy is further studied across Aerobic Exercise and Resistance Training.
  • Based on Program Types, market is studied across Community-Based Programs, Home-Based Programs, and Traditional Programs.
  • Based on End Users, market is studied across Homecare Settings, Hospitals, and Specialty Clinics.
  • Based on Phase Types, market is studied across Phase I, Phase II, and Phase III.
  • Based on Components, market is studied across Behavioral Components, Educational Components, and Exercise Components.
  • Based on Age Groups, market is studied across Adult, Geriatric, and Pediatric.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising healthcare expenditures focused on chronic disease management and preventive healthcare services
      • 5.1.1.2. Expansion of insurance coverage and reimbursement policies for comprehensive cardiac rehabilitation therapies
      • 5.1.1.3. Developments in wearable technology and remote monitoring tools facilitating continuous patient engagement
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of cardiac rehabilitation programs deterring patient enrollment and participation
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of AI-powered tools for early detection and management of cardiac conditions
      • 5.1.3.2. Collaborations between healthcare providers and fitness centers for comprehensive cardiac rehabilitation solutions
    • 5.1.4. Challenges
      • 5.1.4.1. Inconsistent insurance coverage and reimbursement policies affecting patients' access to cardiac rehabilitation services
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cardiac Rehabilitation Market, by Patient Types

  • 6.1. Introduction
  • 6.2. Acute Patients
    • 6.2.1. Post-Surgical
    • 6.2.2. Recently Discharged
  • 6.3. Chronic Patients
    • 6.3.1. Heart Failure Management
    • 6.3.2. Long-Term Follow-Up

7. Cardiac Rehabilitation Market, by Rehabilitation Types

  • 7.1. Introduction
  • 7.2. Inpatient Rehabilitation
    • 7.2.1. Acute Care
    • 7.2.2. Monitoring Services
  • 7.3. Outpatient Rehabilitation
    • 7.3.1. Exercise Therapy
      • 7.3.1.1. Aerobic Exercise
      • 7.3.1.2. Resistance Training
    • 7.3.2. Nutrition Counseling
    • 7.3.3. Psychological Support

8. Cardiac Rehabilitation Market, by Program Types

  • 8.1. Introduction
  • 8.2. Community-Based Programs
  • 8.3. Home-Based Programs
  • 8.4. Traditional Programs

9. Cardiac Rehabilitation Market, by End Users

  • 9.1. Introduction
  • 9.2. Homecare Settings
  • 9.3. Hospitals
  • 9.4. Specialty Clinics

10. Cardiac Rehabilitation Market, by Phase Types

  • 10.1. Introduction
  • 10.2. Phase I
  • 10.3. Phase II
  • 10.4. Phase III

11. Cardiac Rehabilitation Market, by Components

  • 11.1. Introduction
  • 11.2. Behavioral Components
  • 11.3. Educational Components
  • 11.4. Exercise Components

12. Cardiac Rehabilitation Market, by Age Groups

  • 12.1. Introduction
  • 12.2. Adult
  • 12.3. Geriatric
  • 12.4. Pediatric

13. Americas Cardiac Rehabilitation Market

  • 13.1. Introduction
  • 13.2. Argentina
  • 13.3. Brazil
  • 13.4. Canada
  • 13.5. Mexico
  • 13.6. United States

14. Asia-Pacific Cardiac Rehabilitation Market

  • 14.1. Introduction
  • 14.2. Australia
  • 14.3. China
  • 14.4. India
  • 14.5. Indonesia
  • 14.6. Japan
  • 14.7. Malaysia
  • 14.8. Philippines
  • 14.9. Singapore
  • 14.10. South Korea
  • 14.11. Taiwan
  • 14.12. Thailand
  • 14.13. Vietnam

15. Europe, Middle East & Africa Cardiac Rehabilitation Market

  • 15.1. Introduction
  • 15.2. Denmark
  • 15.3. Egypt
  • 15.4. Finland
  • 15.5. France
  • 15.6. Germany
  • 15.7. Israel
  • 15.8. Italy
  • 15.9. Netherlands
  • 15.10. Nigeria
  • 15.11. Norway
  • 15.12. Poland
  • 15.13. Qatar
  • 15.14. Russia
  • 15.15. Saudi Arabia
  • 15.16. South Africa
  • 15.17. Spain
  • 15.18. Sweden
  • 15.19. Switzerland
  • 15.20. Turkey
  • 15.21. United Arab Emirates
  • 15.22. United Kingdom

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2023
  • 16.2. FPNV Positioning Matrix, 2023
  • 16.3. Competitive Scenario Analysis
  • 16.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Allscripts Healthcare Solutions
  • 3. AstraZeneca
  • 4. Boston Scientific
  • 5. Cleveland Clinic
  • 6. Core Health & Fitness
  • 7. Edward Lifesciences Corporation
  • 8. GE Healthcare
  • 9. Johns Hopkins Medicine
  • 10. LifeWatch
  • 11. Mayo Clinic
  • 12. Medtronic
  • 13. Mortara Instrument
  • 14. Novartis
  • 15. Omron Healthcare
  • 16. Pfizer
  • 17. Philips Healthcare
  • 18. Resideo Technologies
  • 19. Siemens Healthineers
  • 20. Smiths Medical

LIST OF FIGURES

  • FIGURE 1. CARDIAC REHABILITATION MARKET RESEARCH PROCESS
  • FIGURE 2. CARDIAC REHABILITATION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CARDIAC REHABILITATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CARDIAC REHABILITATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CARDIAC REHABILITATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CARDIAC REHABILITATION MARKET SIZE, BY PATIENT TYPES, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CARDIAC REHABILITATION MARKET SIZE, BY PATIENT TYPES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CARDIAC REHABILITATION MARKET SIZE, BY REHABILITATION TYPES, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CARDIAC REHABILITATION MARKET SIZE, BY REHABILITATION TYPES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CARDIAC REHABILITATION MARKET SIZE, BY PROGRAM TYPES, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CARDIAC REHABILITATION MARKET SIZE, BY PROGRAM TYPES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CARDIAC REHABILITATION MARKET SIZE, BY END USERS, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CARDIAC REHABILITATION MARKET SIZE, BY END USERS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL CARDIAC REHABILITATION MARKET SIZE, BY PHASE TYPES, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL CARDIAC REHABILITATION MARKET SIZE, BY PHASE TYPES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL CARDIAC REHABILITATION MARKET SIZE, BY COMPONENTS, 2023 VS 2030 (%)
  • FIGURE 17. GLOBAL CARDIAC REHABILITATION MARKET SIZE, BY COMPONENTS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. GLOBAL CARDIAC REHABILITATION MARKET SIZE, BY AGE GROUPS, 2023 VS 2030 (%)
  • FIGURE 19. GLOBAL CARDIAC REHABILITATION MARKET SIZE, BY AGE GROUPS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. AMERICAS CARDIAC REHABILITATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. AMERICAS CARDIAC REHABILITATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. UNITED STATES CARDIAC REHABILITATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 23. UNITED STATES CARDIAC REHABILITATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. ASIA-PACIFIC CARDIAC REHABILITATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 25. ASIA-PACIFIC CARDIAC REHABILITATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 26. EUROPE, MIDDLE EAST & AFRICA CARDIAC REHABILITATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 27. EUROPE, MIDDLE EAST & AFRICA CARDIAC REHABILITATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 28. CARDIAC REHABILITATION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 29. CARDIAC REHABILITATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CARDIAC REHABILITATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CARDIAC REHABILITATION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CARDIAC REHABILITATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CARDIAC REHABILITATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CARDIAC REHABILITATION MARKET DYNAMICS
  • TABLE 7. GLOBAL CARDIAC REHABILITATION MARKET SIZE, BY PATIENT TYPES, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CARDIAC REHABILITATION MARKET SIZE, BY ACUTE PATIENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CARDIAC REHABILITATION MARKET SIZE, BY POST-SURGICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CARDIAC REHABILITATION MARKET SIZE, BY RECENTLY DISCHARGED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CARDIAC REHABILITATION MARKET SIZE, BY ACUTE PATIENTS, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CARDIAC REHABILITATION MARKET SIZE, BY CHRONIC PATIENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CARDIAC REHABILITATION MARKET SIZE, BY HEART FAILURE MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CARDIAC REHABILITATION MARKET SIZE, BY LONG-TERM FOLLOW-UP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CARDIAC REHABILITATION MARKET SIZE, BY CHRONIC PATIENTS, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CARDIAC REHABILITATION MARKET SIZE, BY REHABILITATION TYPES, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CARDIAC REHABILITATION MARKET SIZE, BY INPATIENT REHABILITATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CARDIAC REHABILITATION MARKET SIZE, BY ACUTE CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CARDIAC REHABILITATION MARKET SIZE, BY MONITORING SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CARDIAC REHABILITATION MARKET SIZE, BY INPATIENT REHABILITATION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CARDIAC REHABILITATION MARKET SIZE, BY OUTPATIENT REHABILITATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CARDIAC REHABILITATION MARKET SIZE, BY EXERCISE THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CARDIAC REHABILITATION MARKET SIZE, BY AEROBIC EXERCISE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CARDIAC REHABILITATION MARKET SIZE, BY RESISTANCE TRAINING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CARDIAC REHABILITATION MARKET SIZE, BY EXERCISE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CARDIAC REHABILITATION MARKET SIZE, BY NUTRITION COUNSELING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL CARDIAC REHABILITATION MARKET SIZE, BY PSYCHOLOGICAL SUPPORT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL CARDIAC REHABILITATION MARKET SIZE, BY OUTPATIENT REHABILITATION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL CARDIAC REHABILITATION MARKET SIZE, BY PROGRAM TYPES, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL CARDIAC REHABILITATION MARKET SIZE, BY COMMUNITY-BASED PROGRAMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL CARDIAC REHABILITATION MARKET SIZE, BY HOME-BASED PROGRAMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL CARDIAC REHABILITATION MARKET SIZE, BY TRADITIONAL PROGRAMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL CARDIAC REHABILITATION MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL CARDIAC REHABILITATION MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL CARDIAC REHABILITATION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL CARDIAC REHABILITATION MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL CARDIAC REHABILITATION MARKET SIZE, BY PHASE TYPES, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL CARDIAC REHABILITATION MARKET SIZE, BY PHASE I, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL CARDIAC REHABILITATION MARKET SIZE, BY PHASE II, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL CARDIAC REHABILITATION MARKET SIZE, BY PHASE III, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL CARDIAC REHABILITATION MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL CARDIAC REHABILITATION MARKET SIZE, BY BEHAVIORAL COMPONENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL CARDIAC REHABILITATION MARKET SIZE, BY EDUCATIONAL COMPONENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL CARDIAC REHABILITATION MARKET SIZE, BY EXERCISE COMPONENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL CARDIAC REHABILITATION MARKET SIZE, BY AGE GROUPS, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL CARDIAC REHABILITATION MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL CARDIAC REHABILITATION MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL CARDIAC REHABILITATION MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS CARDIAC REHABILITATION MARKET SIZE, BY PATIENT TYPES, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS CARDIAC REHABILITATION MARKET SIZE, BY ACUTE PATIENTS, 2018-2030 (USD MILLION)
  • TABLE 51. AMERICAS CARDIAC REHABILITATION MARKET SIZE, BY CHRONIC PATIENTS, 2018-2030 (USD MILLION)
  • TABLE 52. AMERICAS CARDIAC REHABILITATION MARKET SIZE, BY REHABILITATION TYPES, 2018-2030 (USD MILLION)
  • TABLE 53. AMERICAS CARDIAC REHABILITATION MARKET SIZE, BY INPATIENT REHABILITATION, 2018-2030 (USD MILLION)
  • TABLE 54. AMERICAS CARDIAC REHABILITATION MARKET SIZE, BY OUTPATIENT REHABILITATION, 2018-2030 (USD MILLION)
  • TABLE 55. AMERICAS CARDIAC REHABILITATION MARKET SIZE, BY EXERCISE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 56. AMERICAS CARDIAC REHABILITATION MARKET SIZE, BY PROGRAM TYPES, 2018-2030 (USD MILLION)
  • TABLE 57. AMERICAS CARDIAC REHABILITATION MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 58. AMERICAS CARDIAC REHABILITATION MARKET SIZE, BY PHASE TYPES, 2018-2030 (USD MILLION)
  • TABLE 59. AMERICAS CARDIAC REHABILITATION MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 60. AMERICAS CARDIAC REHABILITATION MARKET SIZE, BY AGE GROUPS, 2018-2030 (USD MILLION)
  • TABLE 61. AMERICAS CARDIAC REHABILITATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 62. ARGENTINA CARDIAC REHABILITATION MARKET SIZE, BY PATIENT TYPES, 2018-2030 (USD MILLION)
  • TABLE 63. ARGENTINA CARDIAC REHABILITATION MARKET SIZE, BY ACUTE PATIENTS, 2018-2030 (USD MILLION)
  • TABLE 64. ARGENTINA CARDIAC REHABILITATION MARKET SIZE, BY CHRONIC PATIENTS, 2018-2030 (USD MILLION)
  • TABLE 65. ARGENTINA CARDIAC REHABILITATION MARKET SIZE, BY REHABILITATION TYPES, 2018-2030 (USD MILLION)
  • TABLE 66. ARGENTINA CARDIAC REHABILITATION MARKET SIZE, BY INPATIENT REHABILITATION, 2018-2030 (USD MILLION)
  • TABLE 67. ARGENTINA CARDIAC REHABILITATION MARKET SIZE, BY OUTPATIENT REHABILITATION, 2018-2030 (USD MILLION)
  • TABLE 68. ARGENTINA CARDIAC REHABILITATION MARKET SIZE, BY EXERCISE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 69. ARGENTINA CARDIAC REHABILITATION MARKET SIZE, BY PROGRAM TYPES, 2018-2030 (USD MILLION)
  • TABLE 70. ARGENTINA CARDIAC REHABILITATION MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 71. ARGENTINA CARDIAC REHABILITATION MARKET SIZE, BY PHASE TYPES, 2018-2030 (USD MILLION)
  • TABLE 72. ARGENTINA CARDIAC REHABILITATION MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 73. ARGENTINA CARDIAC REHABILITATION MARKET SIZE, BY AGE GROUPS, 2018-2030 (USD MILLION)
  • TABLE 74. BRAZIL CARDIAC REHABILITATION MARKET SIZE, BY PATIENT TYPES, 2018-2030 (USD MILLION)
  • TABLE 75. BRAZIL CARDIAC REHABILITATION MARKET SIZE, BY ACUTE PATIENTS, 2018-2030 (USD MILLION)
  • TABLE 76. BRAZIL CARDIAC REHABILITATION MARKET SIZE, BY CHRONIC PATIENTS, 2018-2030 (USD MILLION)
  • TABLE 77. BRAZIL CARDIAC REHABILITATION MARKET SIZE, BY REHABILITATION TYPES, 2018-2030 (USD MILLION)
  • TABLE 78. BRAZIL CARDIAC REHABILITATION MARKET SIZE, BY INPATIENT REHABILITATION, 2018-2030 (USD MILLION)
  • TABLE 79. BRAZIL CARDIAC REHABILITATION MARKET SIZE, BY OUTPATIENT REHABILITATION, 2018-2030 (USD MILLION)
  • TABLE 80. BRAZIL CARDIAC REHABILITATION MARKET SIZE, BY EXERCISE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 81. BRAZIL CARDIAC REHABILITATION MARKET SIZE, BY PROGRAM TYPES, 2018-2030 (USD MILLION)
  • TABLE 82. BRAZIL CARDIAC REHABILITATION MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 83. BRAZIL CARDIAC REHABILITATION MARKET SIZE, BY PHASE TYPES, 2018-2030 (USD MILLION)
  • TABLE 84. BRAZIL CARDIAC REHABILITATION MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 85. BRAZIL CARDIAC REHABILITATION MARKET SIZE, BY AGE GROUPS, 2018-2030 (USD MILLION)
  • TABLE 86. CANADA CARDIAC REHABILITATION MARKET SIZE, BY PATIENT TYPES, 2018-2030 (USD MILLION)
  • TABLE 87. CANADA CARDIAC REHABILITATION MARKET SIZE, BY ACUTE PATIENTS, 2018-2030 (USD MILLION)
  • TABLE 88. CANADA CARDIAC REHABILITATION MARKET SIZE, BY CHRONIC PATIENTS, 2018-2030 (USD MILLION)
  • TABLE 89. CANADA CARDIAC REHABILITATION MARKET SIZE, BY REHABILITATION TYPES, 2018-2030 (USD MILLION)
  • TABLE 90. CANADA CARDIAC REHABILITATION MARKET SIZE, BY INPATIENT REHABILITATION, 2018-2030 (USD MILLION)
  • TABLE 91. CANADA CARDIAC REHABILITATION MARKET SIZE, BY OUTPATIENT REHABILITATION, 2018-2030 (USD MILLION)
  • TABLE 92. CANADA CARDIAC REHABILITATION MARKET SIZE, BY EXERCISE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 93. CANADA CARDIAC REHABILITATION MARKET SIZE, BY PROGRAM TYPES, 2018-2030 (USD MILLION)
  • TABLE 94. CANADA CARDIAC REHABILITATION MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 95. CANADA CARDIAC REHABILITATION MARKET SIZE, BY PHASE TYPES, 2018-2030 (USD MILLION)
  • TABLE 96. CANADA CARDIAC REHABILITATION MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 97. CANADA CARDIAC REHABILITATION MARKET SIZE, BY AGE GROUPS, 2018-2030 (USD MILLION)
  • TABLE 98. MEXICO CARDIAC REHABILITATION MARKET SIZE, BY PATIENT TYPES, 2018-2030 (USD MILLION)
  • TABLE 99. MEXICO CARDIAC REHABILITATION MARKET SIZE, BY ACUTE PATIENTS, 2018-2030 (USD MILLION)
  • TABLE 100. MEXICO CARDIAC REHABILITATION MARKET SIZE, BY CHRONIC PATIENTS, 2018-2030 (USD MILLION)
  • TABLE 101. MEXICO CARDIAC REHABILITATION MARKET SIZE, BY REHABILITATION TYPES, 2018-2030 (USD MILLION)
  • TABLE 102. MEXICO CARDIAC REHABILITATION MARKET SIZE, BY INPATIENT REHABILITATION, 2018-2030 (USD MILLION)
  • TABLE 103. MEXICO CARDIAC REHABILITATION MARKET SIZE, BY OUTPATIENT REHABILITATION, 2018-2030 (USD MILLION)
  • TABLE 104. MEXICO CARDIAC REHABILITATION MARKET SIZE, BY EXERCISE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 105. MEXICO CARDIAC REHABILITATION MARKET SIZE, BY PROGRAM TYPES, 2018-2030 (USD MILLION)
  • TABLE 106. MEXICO CARDIAC REHABILITATION MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 107. MEXICO CARDIAC REHABILITATION MARKET SIZE, BY PHASE TYPES, 2018-2030 (USD MILLION)
  • TABLE 108. MEXICO CARDIAC REHABILITATION MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 109. MEXICO CARDIAC REHABILITATION MARKET SIZE, BY AGE GROUPS, 2018-2030 (USD MILLION)
  • TABLE 110. UNITED STATES CARDIAC REHABILITATION MARKET SIZE, BY PATIENT TYPES, 2018-2030 (USD MILLION)
  • TABLE 111. UNITED STATES CARDIAC REHABILITATION MARKET SIZE, BY ACUTE PATIENTS, 2018-2030 (USD MILLION)
  • TABLE 112. UNITED STATES CARDIAC REHABILITATION MARKET SIZE, BY CHRONIC PATIENTS, 2018-2030 (USD MILLION)
  • TABLE 113. UNITED STATES CARDIAC REHABILITATION MARKET SIZE, BY REHABILITATION TYPES, 2018-2030 (USD MILLION)
  • TABLE 114. UNITED STATES CARDIAC REHABILITATION MARKET SIZE, BY INPATIENT REHABILITATION, 2018-2030 (USD MILLION)
  • TABLE 115. UNITED STATES CARDIAC REHABILITATION MARKET SIZE, BY OUTPATIENT REHABILITATION, 2018-2030 (USD MILLION)
  • TABLE 116. UNITED STATES CARDIAC REHABILITATION MARKET SIZE, BY EXERCISE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 117. UNITED STATES CARDIAC REHABILITATION MARKET SIZE, BY PROGRAM TYPES, 2018-2030 (USD MILLION)
  • TABLE 118. UNITED STATES CARDIAC REHABILITATION MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 119. UNITED STATES CARDIAC REHABILITATION MARKET SIZE, BY PHASE TYPES, 2018-2030 (USD MILLION)
  • TABLE 120. UNITED STATES CARDIAC REHABILITATION MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 121. UNITED STATES CARDIAC REHABILITATION MARKET SIZE, BY AGE GROUPS, 2018-2030 (USD MILLION)
  • TABLE 122. UNITED STATES CARDIAC REHABILITATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC CARDIAC REHABILITATION MARKET SIZE, BY PATIENT TYPES, 2018-2030 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC CARDIAC REHABILITATION MARKET SIZE, BY ACUTE PATIENTS, 2018-2030 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC CARDIAC REHABILITATION MARKET SIZE, BY CHRONIC PATIENTS, 2018-2030 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC CARDIAC REHABILITATION MARKET SIZE, BY REHABILITATION TYPES, 2018-2030 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC CARDIAC REHABILITATION MARKET SIZE, BY INPATIENT REHABILITATION, 2018-2030 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC CARDIAC REHABILITATION MARKET SIZE, BY OUTPATIENT REHABILITATION, 2018-2030 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC CARDIAC REHABILITATION MARKET SIZE, BY EXERCISE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC CARDIAC REHABILITATION MARKET SIZE, BY PROGRAM TYPES, 2018-2030 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC CARDIAC REHABILITATION MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC CARDIAC REHABILITATION MARKET SIZE, BY PHASE TYPES, 2018-2030 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC CARDIAC REHABILITATION MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC CARDIAC REHABILITATION MARKET SIZE, BY AGE GROUPS, 2018-2030 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC CARDIAC REHABILITATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 136. AUSTRALIA CARDIAC REHABILITATION MARKET SIZE, BY PATIENT TYPES, 2018-2030 (USD MILLION)
  • TABLE 137. AUSTRALIA CARDIAC REHABILITATION MARKET SIZE, BY ACUTE PATIENTS, 2018-2030 (USD MILLION)
  • TABLE 138. AUSTRALIA CARDIAC REHABILITATION MARKET SIZE, BY CHRONIC PATIENTS, 2018-2030 (USD MILLION)
  • TABLE 139. AUSTRALIA CARDIAC REHABILITATION MARKET SIZE, BY REHABILITATION TYPES, 2018-2030 (USD MILLION)
  • TABLE 140. AUSTRALIA CARDIAC REHABILITATION MARKET SIZE, BY INPATIENT REHABILITATION, 2018-2030 (USD MILLION)
  • TABLE 141. AUSTRALIA CARDIAC REHABILITATION MARKET SIZE, BY OUTPATIENT REHABILITATION, 2018-2030 (USD MILLION)
  • TABLE 142. AUSTRALIA CARDIAC REHABILITATION MARKET SIZE, BY EXERCISE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 143. AUSTRALIA CARDIAC REHABILITATION MARKET SIZE, BY PROGRAM TYPES, 2018-2030 (USD MILLION)
  • TABLE 144. AUSTRALIA CARDIAC REHABILITATION MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 145. AUSTRALIA CARDIAC REHABILITATION MARKET SIZE, BY PHASE TYPES, 2018-2030 (USD MILLION)
  • TABLE 146. AUSTRALIA CARDIAC REHABILITATION MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 147. AUSTRALIA CARDIAC REHABILITATION MARKET SIZE, BY AGE GROUPS, 2018-2030 (USD MILLION)
  • TABLE 148. CHINA CARDIAC REHABILITATION MARKET SIZE, BY PATIENT TYPES, 2018-2030 (USD MILLION)
  • TABLE 149. CHINA CARDIAC REHABILITATION MARKET SIZE, BY ACUTE PATIENTS, 2018-2030 (USD MILLION)
  • TABLE 150. CHINA CARDIAC REHABILITATION MARKET SIZE, BY CHRONIC PATIENTS, 2018-2030 (USD MILLION)
  • TABLE 151. CHINA CARDIAC REHABILITATION MARKET SIZE, BY REHABILITATION TYPES, 2018-2030 (USD MILLION)
  • TABLE 152. CHINA CARDIAC REHABILITATION MARKET SIZE, BY INPATIENT REHABILITATION, 2018-2030 (USD MILLION)
  • TABLE 153. CHINA CARDIAC REHABILITATION MARKET SIZE, BY OUTPATIENT REHABILITATION, 2018-2030 (USD MILLION)
  • TABLE 154. CHINA CARDIAC REHABILITATION MARKET SIZE, BY EXERCISE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 155. CHINA CARDIAC REHABILITATION MARKET SIZE, BY PROGRAM TYPES, 2018-2030 (USD MILLION)
  • TABLE 156. CHINA CARDIAC REHABILITATION MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 157. CHINA CARDIAC REHABILITATION MARKET SIZE, BY PHASE TYPES, 2018-2030 (USD MILLION)
  • TABLE 158. CHINA CARDIAC REHABILITATION MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 159. CHINA CARDIAC REHABILITATION MARKET SIZE, BY AGE GROUPS, 2018-2030 (USD MILLION)
  • TABLE 160. INDIA CARDIAC REHABILITATION MARKET SIZE, BY PATIENT TYPES, 2018-2030 (USD MILLION)
  • TABLE 161. INDIA CARDIAC REHABILITATION MARKET SIZE, BY ACUTE PATIENTS, 2018-2030 (USD MILLION)
  • TABLE 162. INDIA CARDIAC REHABILITATION MARKET SIZE, BY CHRONIC PATIENTS, 2018-2030 (USD MILLION)
  • TABLE 163. INDIA CARDIAC REHABILITATION MARKET SIZE, BY REHABILITATION TYPES, 2018-2030 (USD MILLION)
  • TABLE 164. INDIA CARDIAC REHABILITATION MARKET SIZE, BY INPATIENT REHABILITATION, 2018-2030 (USD MILLION)
  • TABLE 165. INDIA CARDIAC REHABILITATION MARKET SIZE, BY OUTPATIENT REHABILITATION, 2018-2030 (USD MILLION)
  • TABLE 166. INDIA CARDIAC REHABILITATION MARKET SIZE, BY EXERCISE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 167. INDIA CARDIAC REHABILITATION MARKET SIZE, BY PROGRAM TYPES, 2018-2030 (USD MILLION)
  • TABLE 168. INDIA CARDIAC REHABILITATION MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 169. INDIA CARDIAC REHABILITATION MARKET SIZE, BY PHASE TYPES, 2018-2030 (USD MILLION)
  • TABLE 170. INDIA CARDIAC REHABILITATION MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 171. INDIA CARDIAC REHABILITATION MARKET SIZE, BY AGE GROUPS, 2018-2030 (USD MILLION)
  • TABLE 172. INDONESIA CARDIAC REHABILITATION MARKET SIZE, BY PATIENT TYPES, 2018-2030 (USD MILLION)
  • TABLE 173. INDONESIA CARDIAC REHABILITATION MARKET SIZE, BY ACUTE PATIENTS, 2018-2030 (USD MILLION)
  • TABLE 174. INDONESIA CARDIAC REHABILITATION MARKET SIZE, BY CHRONIC PATIENTS, 2018-2030 (USD MILLION)
  • TABLE 175. INDONESIA CARDIAC REHABILITATION MARKET SIZE, BY REHABILITATION TYPES, 2018-2030 (USD MILLION)
  • TABLE 176. INDONESIA CARDIAC REHABILITATION MARKET SIZE, BY INPATIENT REHABILITATION, 2018-2030 (USD MILLION)
  • TABLE 177. INDONESIA CARDIAC REHABILITATION MARKET SIZE, BY OUTPATIENT REHABILITATION, 2018-2030 (USD MILLION)
  • TABLE 178. INDONESIA CARDIAC REHABILITATION MARKET SIZE, BY EXERCISE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 179. INDONESIA CARDIAC REHABILITATION MARKET SIZE, BY PROGRAM TYPES, 2018-2030 (USD MILLION)
  • TABLE 180. INDONESIA CARDIAC REHABILITATION MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 181. INDONESIA CARDIAC REHABILITATION MARKET SIZE, BY PHASE TYPES, 2018-2030 (USD MILLION)
  • TABLE 182. INDONESIA CARDIAC REHABILITATION MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 183. INDONESIA CARDIAC REHABILITATION MARKET SIZE, BY AGE GROUPS, 2018-2030 (USD MILLION)
  • TABLE 184. JAPAN CARDIAC REHABILITATION MARKET SIZE, BY PATIENT TYPES, 2018-2030 (USD MILLION)
  • TABLE 185. JAPAN CARDIAC REHABILITATION MARKET SIZE, BY ACUTE PATIENTS, 2018-2030 (USD MILLION)
  • TABLE 186. JAPAN CARDIAC REHABILITATION MARKET SIZE, BY CHRONIC PATIENTS, 2018-2030 (USD MILLION)
  • TABLE 187. JAPAN CARDIAC REHABILITATION MARKET SIZE, BY REHABILITATION TYPES, 2018-2030 (USD MILLION)
  • TABLE 188. JAPAN CARDIAC REHABILITATION MARKET SIZE, BY INPATIENT REHABILITATION, 2018-2030 (USD MILLION)
  • TABLE 189. JAPAN CARDIAC REHABILITATION MARKET SIZE, BY OUTPATIENT REHABILITATION, 2018-2030 (USD MILLION)
  • TABLE 190. JAPAN CARDIAC REHABILITATION MARKET SIZE, BY EXERCISE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 191. JAPAN CARDIAC REHABILITATION MARKET SIZE, BY PROGRAM TYPES, 2018-2030 (USD MILLION)
  • TABLE 192. JAPAN CARDIAC REHABILITATION MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 193. JAPAN CARDIAC REHABILITATION MARKET SIZE, BY PHASE TYPES, 2018-2030 (USD MILLION)
  • TABLE 194. JAPAN CARDIAC REHABILITATION MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 195. JAPAN CARDIAC REHABILITATION MARKET SIZE, BY AGE GROUPS, 2018-2030 (USD MILLION)
  • TABLE 196. MALAYSIA CARDIAC REHABILITATION MARKET SIZE, BY PATIENT TYPES, 2018-2030 (USD MILLION)
  • TABLE 197. MALAYSIA CARDIAC REHABILITATION MARKET SIZE, BY ACUTE PATIENTS, 2018-2030 (USD MILLION)
  • TABLE 198. MALAYSIA CARDIAC REHABILITATION MARKET SIZE, BY CHRONIC PATIENTS, 2018-2030 (USD MILLION)
  • TABLE 199. MALAYSIA CARDIAC REHABILITATION MARKET SIZE, BY REHABILITATION TYPES, 2018-2030 (USD MILLION)
  • TABLE 200. MALAYSIA CARDIAC REHABILITATION MARKET SIZE, BY INPATIENT REHABILITATION, 2018-2030 (USD MILLION)
  • TABLE 201. MALAYSIA CARDIAC REHABILITATION MARKET SIZE, BY OUTPATIENT REHABILITATION, 2018-2030 (USD MILLION)
  • TABLE 202. MALAYSIA CARDIAC REHABILITATION MARKET SIZE, BY EXERCISE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 203. MALAYSIA CARDIAC REHABILITATION MARKET SIZE, BY PROGRAM TYPES, 2018-2030 (USD MILLION)
  • TABLE 204. MALAYSIA CARDIAC REHABILITATION MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 205. MALAYSIA CARDIAC REHABILITATION MARKET SIZE, BY PHASE TYPES, 2018-2030 (USD MILLION)
  • TABLE 206. MALAYSIA CARDIAC REHABILITATION MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 207. MALAYSIA CARDIAC REHABILITATION MARKET SIZE, BY AGE GROUPS, 2018-2030 (USD MILLION)
  • TABLE 208. PHILIPPINES CARDIAC REHABILITATION MARKET SIZE, BY PATIENT TYPES, 2018-2030 (USD MILLION)
  • TABLE 209. PHILIPPINES CARDIAC REHABILITATION MARKET SIZE, BY ACUTE PATIENTS, 2018-2030 (USD MILLION)
  • TABLE 210. PHILIPPINES CARDIAC REHABILITATION MARKET SIZE, BY CHRONIC PATIENTS, 2018-2030 (USD MILLION)
  • TABLE 211. PHILIPPINES CARDIAC REHABILITATION MARKET SIZE, BY REHABILITATION TYPES, 2018-2030 (USD MILLION)
  • TABLE 212. PHILIPPINES CARDIAC REHABILITATION MARKET SIZE, BY INPATIENT REHABILITATION, 2018-2030 (USD MILLION)
  • TABLE 213. PHILIPPINES CARDIAC REHABILITATION MARKET SIZE, BY OUTPATIENT REHABILITATION, 2018-2030 (USD MILLION)
  • TABLE 214. PHILIPPINES CARDIAC REHABILITATION MARKET SIZE, BY EXERCISE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 215. PHILIPPINES CARDIAC REHABILITATION MARKET SIZE, BY PROGRAM TYPES, 2018-2030 (USD MILLION)
  • TABLE 216. PHILIPPINES CARDIAC REHABILITATION MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 217. PHILIPPINES CARDIAC REHABILITATION MARKET SIZE, BY PHASE TYPES, 2018-2030 (USD MILLION)
  • TABLE 218. PHILIPPINES CARDIAC REHABILITATION MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 219. PHILIPPINES CARDIAC REHABILITATION MARKET SIZE, BY AGE GROUPS, 2018-2030 (USD MILLION)
  • TABLE 220. SINGAPORE CARDIAC REHABILITATION MARKET SIZE, BY PATIENT TYPES, 2018-2030 (USD MILLION)
  • TABLE 221. SINGAPORE CARDIAC REHABILITATION MARKET SIZE, BY ACUTE PATIENTS, 2018-2030 (USD MILLION)
  • TABLE 222. SINGAPORE CARDIAC REHABILITATION MARKET SIZE, BY CHRONIC PATIENTS, 2018-2030 (USD MILLION)
  • TABLE 223. SINGAPORE CARDIAC REHABILITATION MARKET SIZE, BY REHABILITATION TYPES, 2018-2030 (USD MILLION)
  • TABLE 224. SINGAPORE CARDIAC REHABILITATION MARKET SIZE, BY INPATIENT REHABILITATION, 2018-2030 (USD MILLION)
  • TABLE 225. SINGAPORE CARDIAC REHABILITATION MARKET SIZE, BY OUTPATIENT REHABILITATION, 2018-2030 (USD MILLION)
  • TABLE 226. SINGAPORE CARDIAC REHABILITATION MARKET SIZE, BY EXERCISE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 227. SINGAPORE CARDIAC REHABILITATION MARKET SIZE, BY PROGRAM TYPES, 2018-2030 (USD MILLION)
  • TABLE 228. SINGAPORE CARDIAC REHABILITATION MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 229. SINGAPORE CARDIAC REHABILITATION MARKET SIZE, BY PHASE TYPES, 2018-2030 (USD MILLION)
  • TABLE 230. SINGAPORE CARDIAC REHABILITATION MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 231. SINGAPORE CARDIAC REHABILITATION MARKET SIZE, BY AGE GROUPS, 2018-2030 (USD MILLION)
  • TABLE 232. SOUTH KOREA CARDIAC REHABILITATION MARKET SIZE, BY PATIENT TYPES, 2018-2030 (USD MILLION)
  • TABLE 233. SOUTH KOREA CARDIAC REHABILITATION MARKET SIZE, BY ACUTE PATIENTS, 2018-2030 (USD MILLION)
  • TABLE 234. SOUTH KOREA CARDIAC REHABILITATION MARKET SIZE, BY CHRONIC PATIENTS, 2018-2030 (USD MILLION)
  • TABLE 235. SOUTH KOREA CARDIAC REHABILITATION MARKET SIZE, BY REHABILITATION TYPES, 2018-2030 (USD MILLION)
  • TABLE 236. SOUTH KOREA CARDIAC REHABILITATION MARKET SIZE, BY INPATIENT REHABILITATION, 2018-2030 (USD MILLION)
  • TABLE 237. SOUTH KOREA CARDIAC REHABILITATION MARKET SIZE, BY OUTPATIENT REHABILITATION, 2018-2030 (USD MILLION)
  • TABLE 238. SOUTH KOREA CARDIAC REHABILITATION MARKET SIZE, BY EXERCISE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 239. SOUTH KOREA CARDIAC REHABILITATION MARKET SIZE, BY PROGRAM TYPES, 2018-2030 (USD MILLION)
  • TABLE 240. SOUTH KOREA CARDIAC REHABILITATION MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 241. SOUTH KOREA CARDIAC REHABILITATION MARKET SIZE, BY PHASE TYPES, 2018-2030 (USD MILLION)
  • TABLE 242. SOUTH KOREA CARDIAC REHABILITATION MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 243. SOUTH KOREA CARDIAC REHABILITATION MARKET SIZE, BY AGE GROUPS, 2018-2030 (USD MILLION)
  • TABLE 244. TAIWAN CARDIAC REHABILITATION MARKET SIZE, BY PATIENT TYPES, 2018-2030 (USD MILLION)
  • TABLE 245. TAIWAN CARDIAC REHABILITATION MARKET SIZE, BY ACUTE PATIENTS, 2018-2030 (USD MILLION)
  • TABLE 246. TAIWAN CARDIAC REHABILITATION MARKET SIZE, BY CHRONIC PATIENTS, 2018-2030 (USD MILLION)
  • TABLE 247. TAIWAN CARDIAC REHABILITATION MARKET SIZE, BY REHABILITATION TYPES, 2018-2030 (USD MILLION)
  • TABLE 248. TAIWAN CARDIAC REHABILITATION MARKET SIZE, BY INPATIENT REHABILITATION, 2018-2030 (USD MILLION)
  • TABLE 249. TAIWAN CARDIAC REHABILITATION MARKET SIZE, BY OUTPATIENT REHABILITATION, 2018-2030 (USD MILLION)
  • TABLE 250. TAIWAN CARDIAC REHABILITATION MARKET SIZE, BY EXERCISE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 251. TAIWAN CARDIAC REHABILITATION MARKET SIZE, BY PROGRAM TYPES, 2018-2030 (USD MILLION)
  • TABLE 252. TAIWAN CARDIAC REHABILITATION MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 253. TAIWAN CARDIAC REHABILITATION MARKET SIZE, BY PHASE TYPES, 2018-2030 (USD MILLION)
  • TABLE 254. TAIWAN CARDIAC REHABILITATION MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 255. TAIWAN CARDIAC REHABILITATION MARKET SIZE, BY AGE GROUPS, 2018-2030 (USD MILLION)
  • TABLE 256. THAILAND CARDIAC REHABILITATION MARKET SIZE, BY PATIENT TYPES, 2018-2030 (USD MILLION)
  • TABLE 257. THAILAND CARDIAC REHABILITATION MARKET SIZE, BY ACUTE PATIENTS, 2018-2030 (USD MILLION)
  • TABLE 258. THAILAND CARDIAC REHABILITATION MARKET SIZE, BY CHRONIC PATIENTS, 2018-2030 (USD MILLION)
  • TABLE 259. THAILAND CARDIAC REHABILITATION MARKET SIZE, BY REHABILITATION TYPES, 2018-2030 (USD MILLION)
  • TABLE 260. THAILAND CARDIAC REHABILITATION MARKET SIZE, BY INPATIENT REHABILITATION, 2018-2030 (USD MILLION)
  • TABLE 261. THAILAND CARDIAC REHABILITATION MARKET SIZE, BY OUTPATIENT REHABILITATION, 2018-2030 (USD MILLION)
  • TABLE 262. THAILAND CARDIAC REHABILITATION MARKET SIZE, BY EXERCISE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 263. THAILAND CARDIAC REHABILITATION MARKET SIZE, BY PROGRAM TYPES, 2018-2030 (USD MILLION)
  • TABLE 264. THAILAND CARDIAC REHABILITATION MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 265. THAILAND CARDIAC REHABILITATION MARKET SIZE, BY PHASE TYPES, 2018-2030 (USD MILLION)
  • TABLE 266. THAILAND CARDIAC REHABILITATION MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 267. THAILAND CARDIAC REHABILITATION MARKET SIZE, BY AGE GROUPS, 2018-2030 (USD MILLION)
  • TABLE 268. VIETNAM CARDIAC REHABILITATION MARKET SIZE, BY PATIENT TYPES, 2018-2030 (USD MILLION)
  • TABLE 269. VIETNAM CARDIAC REHABILITATION MARKET SIZE, BY ACUTE PATIENTS, 2018-2030 (USD MILLION)
  • TABLE 270. VIETNAM CARDIAC REHABILITATION MARKET SIZE, BY CHRONIC PATIENTS, 2018-2030 (USD MILLION)
  • TABLE 271. VIETNAM CARDIAC REHABILITATION MARKET SIZE, BY REHABILITATION TYPES, 2018-2030 (USD MILLION)
  • TABLE 272. VIETNAM CARDIAC REHABILITATION MARKET SIZE, BY INPATIENT REHABILITATION, 2018-2030 (USD MILLION)
  • TABLE 273. VIETNAM CARDIAC REHABILITATION MARKET SIZE, BY OUTPATIENT REHABILITATION, 2018-2030 (USD MILLION)
  • TABLE 274. VIETNAM CARDIAC REHABILITATION MARKET SIZE, BY EXERCISE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 275. VIETNAM CARDIAC REHABILITATION MARKET SIZE, BY PROGRAM TYPES, 2018-2030 (USD MILLION)
  • TABLE 276. VIETNAM CARDIAC REHABILITATION MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 277. VIETNAM CARDIAC REHABILITATION MARKET SIZE, BY PHASE TYPES, 2018-2030 (USD MILLION)
  • TABLE 278. VIETNAM CARDIAC REHABILITATION MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 279. VIETNAM CARDIAC REHABILITATION MARKET SIZE, BY AGE GROUPS, 2018-2030 (USD MILLION)
  • TABLE 280. EUROPE, MIDDLE EAST & AFRICA CARDIAC REHABILITATION MARKET SIZE, BY PATIENT TYPES, 2018-2030 (USD MILLION)
  • TABLE 281. EUROPE, MIDDLE EAST & AFRICA CARDIAC REHABILITATION MARKET SIZE, BY ACUTE PATIENTS, 2018-2030 (USD MILLION)
  • TABLE 282. EUROPE, MIDDLE EAST & AFRICA CARDIAC REHABILITATION MARKET SIZE, BY CHRONIC PATIENTS, 2018-2030 (USD MILLION)
  • TABLE 283. EUROPE, MIDDLE EAST & AFRICA CARDIAC REHABILITATION MARKET SIZE, BY REHABILITATION TYPES, 2018-2030 (USD MILLION)
  • TABLE 284. EUROPE, MIDDLE EAST & AFRICA CARDIAC REHABILITATION MARKET SIZE, BY INPATIENT REHABILITATION, 2018-2030 (USD MILLION)
  • TABLE 285. EUROPE, MIDDLE EAST & AFRICA CARDIAC REHABILITATION MARKET SIZE, BY OUTPATIENT REHABILITATION, 2018-2030 (USD MILLION)
  • TABLE 286. EUROPE, MIDDLE EAST & AFRICA CARDIAC REHABILITATION MARKET SIZE, BY EXERCISE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 287. EUROPE, MIDDLE EAST & AFRICA CARDIAC REHABILITATION MARKET SIZE, BY PROGRAM TYPES, 2018-2030 (USD MILLION)
  • TABLE 288. EUROPE, MIDDLE EAST & AFRICA CARDIAC REHABILITATION MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 289. EUROPE, MIDDLE EAST & AFRICA CARDIAC REHABILITATION MARKET SIZE, BY PHASE TYPES, 2018-2030 (USD MILLION)
  • TABLE 290. EUROPE, MIDDLE EAST & AFRICA CARDIAC REHABILITATION MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 291. EUROPE, MIDDLE EAST & AFRICA CARDIAC REHABILITATION MARKET SIZE, BY AGE GROUPS, 2018-2030 (USD MILLION)
  • TABLE 292. EUROPE, MIDDLE EAST & AFRICA CARDIAC REHABILITATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 293. DENMARK CARDIAC REHABILITATION MARKET SIZE, BY PATIENT TYPES, 2018-2030 (USD MILLION)
  • TABLE 294. DENMARK CARDIAC REHABILITATION MARKET SIZE, BY ACUTE PATIENTS, 2018-2030 (USD MILLION)
  • TABLE 295. DENMARK CARDIAC REHABILITATION MARKET SIZE, BY CHRONIC PATIENTS, 2018-2030 (USD MILLION)
  • TABLE 296. DENMARK CARDIAC REHABILITATION MARKET SIZE, BY REHABILITATION TYPES, 2018-2030 (USD MILLION)
  • TABLE 297. DENMARK CARDIAC REHABILITATION MARKET SIZE, BY INPATIENT REHABILITATION, 2018-2030 (USD MILLION)
  • TABLE 298. DENMARK CARDIAC REHABILITATION MARKET SIZE, BY OUTPATIENT REHABILITATION, 2018-2030 (USD MILLION)
  • TABLE 299. DENMARK CARDIAC REHABILITATION MARKET SIZE, BY EXERCISE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 300. DENMARK CARDIAC REHABILITATION MARKET SIZE, BY PROGRAM TYPES, 2018-2030 (USD MILLION)
  • TABLE 301. DENMARK CARDIAC REHABILITATION MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 302. DENMARK CARDIAC REHABILITATION MARKET SIZE, BY PHASE TYPES, 2018-2030 (USD MILLION)
  • TABLE 303. DENMARK CARDIAC REHABILITATION MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 304. DENMARK CARDIAC REHABILITATION MARKET SIZE, BY AGE GROUPS, 2018-2030 (USD MILLION)
  • TABLE 305. EGYPT CARDIAC REHABILITATION MARKET SIZE, BY PATIENT TYPES, 2018-2030 (USD MILLION)
  • TABLE 306. EGYPT CARDIAC REHABILITATION MARKET SIZE, BY ACUTE PATIENTS, 2018-2030 (USD MILLION)
  • TABLE 307. EGYPT CARDIAC REHABILITATION MARKET SIZE, BY CHRONIC PATIENTS, 2018-2030 (USD MILLION)
  • TABLE 308. EGYPT CARDIAC REHABILITATION MARKET SIZE, BY REHABILITATION TYPES, 2018-2030 (USD MILLION)
  • TABLE 309. EGYPT CARDIAC REHABILITATION MARKET SIZE, BY INPATIENT REHABILITATION, 2018-2030 (USD MILLION)
  • TABLE 310. EGYPT CARDIAC REHABILITATION MARKET SIZE, BY OUTPATIENT REHABILITATION, 2018-2030 (USD MILLION)
  • TABLE 311. EGYPT CARDIAC REHABILITATION MARKET SIZE, BY EXERCISE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 312. EGYPT CARDIAC REHABILITATION MARKET SIZE, BY PROGRAM TYPES, 2018-2030 (USD MILLION)
  • TABLE 313. EGYPT CARDIAC REHABILITATION MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 314. EGYPT CARDIAC REHABILITATION MARKET SIZE, BY PHASE TYPES, 2018-2030 (USD MILLION)
  • TABLE 315. EGYPT CARDIAC REHABILITATION MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 316. EGYPT CARDIAC REHABILITATION MARKET SIZE, BY AGE GROUPS, 2018-2030 (USD MILLION)
  • TABLE 317. FINLAND CARDIAC REHABILITATION MARKET SIZE, BY PATIENT TYPES, 2018-2030 (USD MILLION)
  • TABLE 318. FINLAND CARDIAC REHABILITATION MARKET SIZE, BY ACUTE PATIENTS, 2018-2030 (USD MILLION)
  • TABLE 319. FINLAND CARDIAC REHABILITATION MARKET SIZE, BY CHRONIC PATIENTS, 2018-2030 (USD MILLION)
  • TABLE 320. FINLAND CARDIAC REHABILITATION MARKET SIZE, BY REHABILITATION TYPES, 2018-2030 (USD MILLION)
  • TABLE 321. FINLAND CARDIAC REHABILITATION MARKET SIZE, BY INPATIENT REHABILITATION, 2018-2030 (USD MILLION)
  • TABLE 322. FINLAND CARDIAC REHABILITATION MARKET SIZE, BY OUTPATIENT REHABILITATION, 2018-2030 (USD MILLION)
  • TABLE 323. FINLAND CARDIAC REHABILITATION MARKET SIZE, BY EXERCISE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 324. FINLAND CARDIAC REHABILITATION MARKET SIZE, BY PROGRAM TYPES, 2018-2030 (USD MILLION)
  • TABLE 325. FINLAND CARDIAC REHABILITATION MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 326. FINLAND CARDIAC REH